When was Zilia founded?

Zilia was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Zilia located?

Zilia is headquartered in Quebec City, Canada.

How many employees does Zilia have?

As of May 27, 2025, the latest employee count at Zilia is 49.

Is Zilia a funded company?

Zilia is a funded company, having raised a total of $4.98M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 11, 2021.

When was the latest funding round of Zilia?

Zilia's latest funding was a $***** Seed round on Apr 17, 2025, with participation from 0 investor. Its primary sector is Ophthalmology. Globally, the Ophthalmology sector has seen $1.35B in funding in 2026 to date.

Where does Zilia rank among its competitors?

Zilia ranks 2nd amongst 40 active competitors, of which 14 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Zilia, which secured $985K in Apr, 2025.

Who are the top competitors of Zilia?

Zilia's top competitors include EyeNetra, Voptica and BroadSpot Imaging. Among them, Zilia secured the most recent funding round in April, 2025.

Zilia - 2026 Company Profile, Team, Funding & Competitors

Zilia is a seed company based in Quebec City (Canada), founded in 2018 by Dominic Sauvageau. It operates as a Developer of non-invasive ocular oximetry technologies. Zilia has raised $4.98M in funding from Anges Quebec. The company has 40 active competitors, including 14 funded and 4 that have exited. Its top competitors include companies like EyeNetra, Voptica and BroadSpot Imaging.

Company Details

Developer of non-invasive ocular oximetry technologies. The company offers its propriety technology for the early detection of ocular disease. The company offers full light spectrum technology to measure the oxygen in ocular and to measure the biomarker in the eye and information on the metabolic state of the eye.

Website: ziliahealth.com
Email ID: *****@ziliahealth.com
Phone Number: +1 **********

Key Metrics

Founded Year

2018

Location

Quebec City, Canada

Stage

Seed

Total Funding

$4.98M in 2 rounds

Latest Funding Round

Seed, Apr 17, 2025, $*****

Investors

Anges Quebec

Ranked

2^nd among 40 active competitors

Employee Count

49 as on May 27, 2025

Similar Companies

EyeNetra & 44 more

View Zilia's full profile

Zilia has raised a total funding of $4.98M over 2 rounds. Its first funding round was on Aug 11, 2021. Zilia has 1 institutional investor.

Here is the list of recent funding rounds of Zilia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 17, 2025	5003745	Seed	9059048	6138548	7139515	9710945
Aug 11, 2021	5128681	Seed	8315416	4550431	Anges Quebec	8169629

Access funding benchmarks and valuations. Sign up today!

View details of Zilia's funding rounds and investors

The founders of Zilia is Dominic Sauvageau.

Here are the details of Zilia's key team members:

Dominic Sauvageau: Co-Founder of Zilia and founder of 1 other company.
Contact Info: 1 email address

View details of Zilia's Founder profiles and Board Members

Zilia's employee count trend

Zilia has 49 employees as of May 25. Here is Zilia's employee count trend over the years:

Uncover Zilia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Zilia include EyeNetra, Voptica and BroadSpot Imaging. Here is the list of Top 10 competitors of Zilia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	EyeNetra 2011, Somerville (United States), Series A	Smartphone-powered vision testing tools for eye care professionals, enabling mobile refraction	$7M	Khosla Impact, Khosla Ventures & 1 others	55/100
2nd	Zilia 2018, Quebec City (Canada), Seed	Developer of non-invasive ocular oximetry technologies	$4.98M	Anges Quebec	46/100
3rd	Voptica 2010, Murcia (Spain), Series A	Adaptive optics based visual simulator which allows the patient to experience personalized optical solutions before implementation	-	Europa, EIC Fund & 1 others	45/100
4th	BroadSpot Imaging 2013, San Francisco (United States), Series A	Ophthalmological imaging devices for anterior as well as posterior regions	$8.6M	Phoenix Venture Partners, BlueStone Venture Partners ... & 2 others	43/100
5th	OCULUS 1895, Frankfurt Am Main (Germany), Funding Raised	Range of eye diagnostic equipment	-	Europa	41/100
6th	PlenOptika 2014, Cambridge (United States), Seed	Developer of a medical devices for measuring refractive errors	$50.4K	Oakhouse Partners, Nina Capital & 4 others	41/100
7th	machineMD 2019, Bern (Switzerland), Seed	Developer of a device for the diagnosis of brain disease	$4.77M	Guido Fluri Stiftung, Swiss ICT Investor Club ... & 3 others	39/100
8th	ArcScan 2007, Golden (United States), Public	Ultrasound device for micron resolution imaging of the anterior chamber	$15.5M	McGovern Center, Shanghai Haohai Biological Technology ... Read more	35/100
9th	M&S Technologies 1990, Niles (United States), Acquired	Computerized vision testing systems for eye care professionals, improving accuracy	-	-	34/100
10th	Smart Vision Labs 2013, New York City (United States), Series A	Smartphone attachment to test for errors of refraction	$6.1M	Techstars, TYLT Ventures & 4 others	32/100